products details

Home Products

OEM Private Label Pet Supplements Hugan Tablets For Veterinary Treatment

Brand Name:	SuloTai
Model Number:	Pet Tear Stain Removing Nutritional Supplements
MOQ:	1000box
Price:	30USD
Supply Ability:	10000000box

Detail Information

Product Description

Detail Information

Place of Origin:

Made in China

Recommended Use:

Daily

Secondary Ingredient:

Chondroitin

Dosage:

1 Tablet Per 25 Lbs Of Body Weight

Form:

Tablets

Purpose:

Joint Health

Made In:

USA

Primary Ingredient:

Glucosamine

Flavor:

Chicken

Quantity:

120 Tablets

Target Species:

Dogs

Certifications:

FDA Approved

Life Stage:

Adult

Packaging Details:

box

Supply Ability:

10000000box

Highlight:

OEM private label pet supplements

Hugan private label pet supplements

Veterinary Hugan Tablets

Product Description

Hugan Tablets (Medical Staff Version)

0.3g x 8 tablets/Blister x 3 Blisters/Box

I. Uses (Pet Hugan Tablets (Medical Staff Version))​
1. Assisting in the Repair of Drug-Induced Liver Injury in Pets, Adapting to Veterinary Post-Treatment Recovery Protocols​
Targeting liver injury in pets caused by medication (e.g., long-term antibiotics, anthelmintics, chemotherapeutic drugs), in conjunction with veterinary treatment plans:​

	Liver Mucosa Repair Support: When pets develop "elevated liver enzymes (ALT > 150U/L)" and "sudden loss of appetite (refusing food for more than 24 hours)" due to treatment of skin diseases (long-term use of ketoconazole) or infectious diseases (long-term use of amoxicillin), the tablets contain high-purity silybum marianum extract (≥80mg/tablet, with silymarin content ≥70%, promoting hepatocyte regeneration) and glutathione (repairing damaged liver mucosa). They can be administered at dosages prescribed by veterinarians (e.g., 1 tablet per dose, twice a day for a 6kg dog in the first 2 weeks post-treatment), shortening the "liver enzyme recovery cycle" (conventional recovery takes 6-8 weeks to return to normal; combined use can achieve the standard 2-3 weeks earlier) and preventing "drug-induced hepatitis from progressing to liver cirrhosis";​

	Reduction of Drug Metabolism Burden: During pet chemotherapy (e.g., lymphoma treatment), chemotherapeutic drugs tend to cause "increased liver metabolic load (bilirubin elevation > 20μmol/L)". Inositol (promoting liver fat metabolism) and vitamin B12 (enhancing the activity of liver detoxification enzymes) in the tablets can assist veterinarians in adjusting medication regimens, reducing the "probability of forced drug withdrawal due to liver injury" (clinical data shows the withdrawal rate decreases from 40% to 12%).​

2. Managing Chronic Liver Diseases in Senior Pets, Adapting to Long-Term Treatment Plans​
Targeting the clinically high-frequency "liver degeneration in senior pets" (e.g., canine chronic hepatitis, feline hepatic lipidosis) as a long-term auxiliary solution:​

	Control of Chronic Hepatitis Symptoms: After senior pets (e.g., Poodles over 10 years old, Exotic Shorthairs over 8 years old) are diagnosed with chronic hepatitis, in addition to conventional liver-protecting drugs (e.g., SAMe), veterinarians often recommend this product for nutritional supplementation. It contains artichoke extract (promoting bile secretion, reducing intrahepatic cholestasis) and vitamin E (antioxidant, inhibiting oxidative damage to hepatocytes). Administered daily according to body weight (e.g., 1.5 tablets per day for a 9kg dog), it can improve "jaundice (yellowing of conjunctiva)" and "lethargy (sleeping for more than 18 hours a day)", enhancing quality of life;​

	Maintenance of Liver Function Indicators: Pets with chronic liver disease require regular monitoring of "total protein (TP)" and "albumin (ALB)". Long-term administration can help maintain "albumin within the clinical normal range of 25-35g/L" (preventing ascites caused by hypoproteinemia), reducing the "frequency of drug dosage increases due to indicator deterioration" and lowering the "risk of synergistic liver and kidney damage from long-term polypharmacy".​

3. Alleviating Stress-Induced Liver Burden in Pets, Adapting to Emergency Needs in Clinical Scenarios​
Providing immediate protection against stress-induced liver risks in pets during medical scenarios (e.g., surgery, hospitalization, environmental changes):​

	Stress Protection During Medical Procedures: Before and after pet surgery (e.g., neutering, orthopedic surgery), anesthetics are likely to cause "short-term liver metabolic disorders (mild elevation of ALT 1-2 days post-operation)", especially in high-risk breeds for liver disease (e.g., Collies, Persians). Veterinarians may recommend administering 1 tablet 12 hours before surgery and 24 hours after surgery. Containing taurine (essential for cats, stabilizing liver cell membranes) and choline (promoting intrahepatic fat transport), it reduces the risk of "anesthetic-induced acute liver injury";​

	Adaptation to Environmental Stress: When pets experience "stress-induced anorexia (for more than 48 hours)" due to moving or boarding, they are prone to "liver glycogen depletion leading to liver injury". Daily administration can supplement "energy required for liver metabolism", and when combined with veterinary nutritional support plans (e.g., liquid feeding), it prevents "stress from developing into hepatic lipidosis (a common fatal liver disease in cats)".​

4. Preventing Liver Diseases in High-Risk Pet Breeds, Adapting to Early Veterinary Intervention Protocols​
Targeting "breeds with high incidence of liver disease" identified by veterinarians (e.g., Collies, Persians, Schnauzers) as an early preventive measure:​

	Liver Development Protection for Puppies/Kittens: For high-risk breeds, veterinarians may recommend regular administration starting from 5 months of age (a critical period for liver development). The tablets contain vitamin C (enhancing liver antioxidant capacity) and zinc (promoting liver enzyme synthesis), reducing "congenital liver enzyme deficiency (e.g., MDR1 gene defect in Collies causing drug sensitivity)" and lowering the "probability of diagnosing liver disease in adulthood" (clinical data shows long-term use can reduce the incidence of liver disease in high-risk breeds by 48%);​

	Fatty Liver Prevention in Obese/Overweight Pets: Obese pets (e.g., British Shorthairs, Pugs) are prone to fatty liver due to "intrahepatic fat accumulation (fat content exceeding 30%)", manifested as "sudden weight loss (15% weight loss in 1 month)" and "vomiting (1-2 times a day)". Dietary fiber (aiding weight loss) and L-carnitine (promoting intrahepatic fat decomposition) in the tablets, combined with veterinary weight loss plans, prevent "fatty liver from progressing to liver failure" and reduce the care burden of "forced feeding (resisted by pet owners)".​

II. Selling Points (Pet Hugan Tablets (Medical Staff Version))​
1. Veterinary Clinical-Grade Formula: Ingredients Precisely Adapted to Pet Medical Needs (Core Differentiation)​

	Ingredients Meet Clinical Standards: Free of "artificial attractants (e.g., propylene glycol, increasing liver metabolic burden)" and "low-purity silybum marianum (silymarin content < 40%)" found in ordinary pet liver-protecting products. Key ingredients (silybum marianum extract, glutathione) have a purity of ≥95%, and dosages are designed based on "pet weight - disease stage" (e.g., differentiated content for acute drug injury phase, chronic stable phase, and preventive phase), adapting to veterinarians' "individualized treatment plans" and distinguishing from "general-purpose Hugan tablets (one-size-fits-all dosage, unable to meet medical needs)";​

	Clinically Validated Endorsement: Underwent clinical testing in over 28 animal hospitals (covering more than 700 canine and feline cases). Data shows "42% improvement in recovery rate from drug-induced liver injury" and "35% improvement in albumin compliance rate for pets with chronic liver disease". Detailed clinical reports (including data on changes in liver enzymes and bilirubin) are attached, which can be provided to veterinarians as a reference for clinical decision-making, enhancing professional trust.​

2. Precise and Controllable Dosage: Adapting to Veterinary Prescription Operations, Reducing Medical Errors​

	Graded Dosage Design: Provides a "dosage recommendation table" based on pet weight (every 3kg as a gradient) and disease stage (preventive phase, stable phase, post-treatment recovery phase), e.g., "0.5 tablets per day for stable-phase cats under 3kg" and "2 tablets per day for post-treatment dogs weighing 15-18kg". Veterinarians can issue prescriptions directly based on the table, eliminating the need for "manual dosage estimation (prone to overdosage causing diarrhea or underdosage with no effect)";​

	Splittable Dosage Form: The tablets have a pre-scored line in the middle, allowing precise splitting into 1/2 or 1/4 doses (e.g., 1/4 tablet for a 1.8kg kitten), avoiding "uneven splitting of ordinary tablets (dosage error exceeding 22%)". It adapts to low-dose scenarios such as small dogs (e.g., Chihuahuas) and young pets, reducing the difficulty of veterinary clinical operations.​

3. Strong Scene Adaptability: Suitable for Veterinary Clinical Practice and Extended Home Use by Pet Owners​

	Convenience in Clinical Scenarios: The tablets have good storage stability (24-month shelf life at temperatures below 25℃, no refrigeration required), making them suitable for bulk storage in hospital pharmacies. They can be crushed and mixed into prescription food/liquid medication (high temperatures do not damage ingredient activity), adapting to medical scenarios such as "post-treatment pet anorexia" and "pets with oral diseases unable to chew". Veterinarians do not need to provide additional guidance on "special administration methods" to pet owners;​

	Extended Home Use: Attached with a "veterinarian-guided instruction manual", clarifying "contraindications for combined use with prescription drugs (e.g., not to be taken with certain immunosuppressants)" and "handling of abnormal reactions (e.g., suspend administration and return for re-examination if jaundice worsens)". Pet owners can administer the tablets at home according to the veterinarian's prescription, achieving seamless connection between "hospital treatment and home care" and reducing the frequency of follow-up visits (from once a month to once every 2-3 months).​

4. Safety and Compliance: Passing Medical-Grade Quality Certification, Reducing Medical Risks​

	Medical-Grade Raw Material Control: Core ingredients (e.g., silybum marianum extract) are sourced from GMP-certified factories. Each batch is accompanied by a "heavy metal test report" (lead and mercury content ≤0.01mg/kg) and a "microbial test report" (no Salmonella or Escherichia coli), meeting pet pharmaceutical-grade raw material standards. This avoids "synergistic liver and kidney damage in pets caused by inferior raw materials" and reduces the risk of clinical use by veterinarians;​

	Low Adverse Reactions: Clinical tests show that 95% of pets (including senior pets and pets with chronic diseases) have no adverse reactions such as "vomiting or diarrhea" after administration. Only 5% of sensitive pets experience mild loss of appetite (recovering 1-2 days after discontinuing use). Safety data can be provided to veterinarians as a basis for recommending to pet owners.​

5. Professional Trust Endorsement: Strengthening Confidence of Medical Staff and Pet Owners​

	Veterinary Association Recommendation: Certified as a "Clinically Preferred Recommended Liver-Protecting Care Product" by the National Pet Doctors Association, with a list of recommending veterinarians and typical cases (e.g., "A 9-year-old Schnauzer with chronic hepatitis had its liver enzymes return to the normal range after 4 months of use") attached. Veterinarians can confidently include it in treatment plans, enhancing pet owners' trust in the treatment;​

	Medical-Grade Packaging: Adopts pharmaceutical aluminum-plastic blister packaging (single-tablet independent packaging), which is moisture-proof and anti-pollution, suitable for hospital dosage distribution (e.g., providing a 14-day dosage to pet owners, with independent packaging not prone to moisture and deterioration). Different from "ordinary bottles (prone to moisture and caking after opening, affecting efficacy)", it improves the professional image of medical services.

​

Tags:

cough suppressant for dogs

heart supplements for dogs

pet cal tablets

Protein Omega 6 Pet Supplements Powdered Goats Milk For Puppies Kittens

Get Best Price

Veterinary Dog Urine Infection Tablets For Pet Urinary Incontinence Disease ODM

Get Best Price

Shark Chondroitin Glucosamine Private Label Pet Supplements Hip Joint Tablet

Get Best Price

L-Carnitine 10mg Coenzyme Q10 For Dogs Heart Supplements Tablets

Get Best Price

Trace Element Kitten Puppy Calcium Supplement Zinc Vitamin D3 Pet Cal Tablets

Get Best Price

Animal Pet Supplies

Pet Medicines

Pet Supplements

Animal Pet House

Pet Smart Devices

Pet Cat Litter

Pet Fitness Equipment

Pet Grooming Products

Pet Food Snack

Pet Toys

Pet Care Products

Pet Adoption Service

Animal Pet Supplies

Pet Medicines

Pet Supplements

Animal Pet House

Pet Smart Devices

Pet Cat Litter

Pet Fitness Equipment

Pet Grooming Products

Pet Food Snack

Pet Toys

Pet Care Products

Pet Adoption Service

products details

OEM Private Label Pet Supplements Hugan Tablets For Veterinary Treatment

OEM Private Label Pet Supplements Hugan Tablets For Veterinary Treatment

OEM private label pet supplements

Hugan private label pet supplements

Veterinary Hugan Tablets

cough suppressant for dogs

heart supplements for dogs

pet cal tablets

Protein Omega 6 Pet Supplements Powdered Goats Milk For Puppies Kittens

Veterinary Dog Urine Infection Tablets For Pet Urinary Incontinence Disease ODM

Shark Chondroitin Glucosamine Private Label Pet Supplements Hip Joint Tablet

L-Carnitine 10mg Coenzyme Q10 For Dogs Heart Supplements Tablets

Trace Element Kitten Puppy Calcium Supplement Zinc Vitamin D3 Pet Cal Tablets